Alex Nivorozhkin

1.3k total citations · 1 hit paper
7 papers, 1.0k citations indexed

About

Alex Nivorozhkin is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alex Nivorozhkin has authored 7 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alex Nivorozhkin's work include Biosimilars and Bioanalytical Methods (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Chemical synthesis and alkaloids (2 papers). Alex Nivorozhkin is often cited by papers focused on Biosimilars and Bioanalytical Methods (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Chemical synthesis and alkaloids (2 papers). Alex Nivorozhkin collaborates with scholars based in United States, Australia and Hungary. Alex Nivorozhkin's co-authors include Pál Pacher, Csaba Szabó, Ja Hye Myung, Darby Kozak, Seongkyu Yoon, Benjamin Rivnay, Hao Tian, Peter Petrochenko, Muhammad Ashraf and Yanling Liu and has published in prestigious journals such as Pharmacological Reviews, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Alex Nivorozhkin

7 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol

2006 982 citations Pál Pacher, Alex Nivorozhkin et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Nivorozhkin United States	4	465	386	152	132	127	7	1.0k
Xinyan Chen China	16	203 0.4×	412 1.1×	54 0.4×	107 0.8×	110 0.9×	81	999
Qi Dong China	22	139 0.3×	495 1.3×	174 1.1×	98 0.7×	84 0.7×	87	1.4k
Byung‐Hoon Lee South Korea	23	143 0.3×	557 1.4×	182 1.2×	157 1.2×	124 1.0×	70	1.4k
Zhiyong Wang China	15	145 0.3×	380 1.0×	95 0.6×	58 0.4×	72 0.6×	35	1.1k
Weigang Duan China	16	145 0.3×	411 1.1×	143 0.9×	116 0.9×	67 0.5×	41	908
Eun Soo Lee South Korea	20	204 0.4×	332 0.9×	68 0.4×	92 0.7×	113 0.9×	51	1.3k
Kazumasa Aoyagi Japan	20	149 0.3×	412 1.1×	107 0.7×	112 0.8×	82 0.6×	70	1.4k
Shan Lu China	22	102 0.2×	521 1.3×	150 1.0×	72 0.5×	67 0.5×	53	1.4k
Lin Huang China	22	74 0.2×	460 1.2×	73 0.5×	74 0.6×	92 0.7×	103	1.3k
Wanghui Jing China	22	102 0.2×	759 2.0×	204 1.3×	72 0.5×	179 1.4×	54	1.7k

Countries citing papers authored by Alex Nivorozhkin

Since Specialization

Citations

This map shows the geographic impact of Alex Nivorozhkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Nivorozhkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Nivorozhkin more than expected).

Fields of papers citing papers by Alex Nivorozhkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Nivorozhkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Nivorozhkin. The network helps show where Alex Nivorozhkin may publish in the future.

Co-authorship network of co-authors of Alex Nivorozhkin

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Nivorozhkin. A scholar is included among the top collaborators of Alex Nivorozhkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Nivorozhkin. Alex Nivorozhkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Palfreyman, Michael G., et al.. (2025). Modification of natural tryptamines for the treatment of neuropsychiatric diseases. Journal of Psychopharmacology. 39(12). 1338–1350. 1 indexed citations

2.

Varty, Geoffrey B., Clinton E. Canal, Joshua A. Hartsel, et al.. (2024). Synthesis and Structure–Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT₂ Receptor Agonist. Journal of Medicinal Chemistry. 67(8). 6144–6188. 1 indexed citations

3.

Liu, Yanling, Benjamin Rivnay, Ja Hye Myung, et al.. (2020). Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach. International Journal of Pharmaceutics. 585. 119473–119473. 14 indexed citations

4.

Rivnay, Benjamin, Peter Petrochenko, Ja Hye Myung, et al.. (2019). Critical process parameters in manufacturing of liposomal formulations of amphotericin B. International Journal of Pharmaceutics. 565. 447–457. 32 indexed citations

5.

Nivorozhkin, Alex. (2019). Solubilization of Phytocannabinoids Using Cyclodextrins. 1 indexed citations

6.

Tian, Hao, et al.. (2013). Probing pharmaceutical powder blending uniformity with electrostatic charge measurements. Powder Technology. 245. 64–69. 15 indexed citations

7.

Pacher, Pál, Alex Nivorozhkin, & Csaba Szabó. (2006). Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol. Pharmacological Reviews. 58(1). 87–114. 982 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact